BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9557363)

  • 1. [A reasoned approach to the pharmacologic treatment of Alzheimer's disease].
    Espinàs J; Monjo M
    Aten Primaria; 1998 Jan; 21(1):60-2. PubMed ID: 9557363
    [No Abstract]   [Full Text] [Related]  

  • 2. NICE insiders criticise Alzheimer's drug decision.
    Gould M
    Health Serv J; 2006 Oct; 116(6028):8. PubMed ID: 17086921
    [No Abstract]   [Full Text] [Related]  

  • 3. High Court upholds NICE decision to limit treatments for Alzheimer's disease.
    Dyer O
    BMJ; 2007 Aug; 335(7615):319. PubMed ID: 17703017
    [No Abstract]   [Full Text] [Related]  

  • 4. A request for the 'Alzheimer's drug'.
    Roscoe T; Robertson M; Hastie I
    Practitioner; 1997 Jul; 241(1576):365-8, 370. PubMed ID: 9425709
    [No Abstract]   [Full Text] [Related]  

  • 5. Effective pharmacologic management of Alzheimer's disease.
    Farlow MR; Cummings JL
    Am J Med; 2007 May; 120(5):388-97. PubMed ID: 17466645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing health economic outcome in Alzheimer's disease clinical trials.
    Jonsson L
    J Nutr Health Aging; 2007; 11(4):353-5. PubMed ID: 17653498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired decision-making ability in subjects with Alzheimer's disease and willingness to participate in research.
    Kim SY; Cox C; Caine ED
    Am J Psychiatry; 2002 May; 159(5):797-802. PubMed ID: 11986134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term benefits of early pharmacologic treatment in Alzheimer's disease. Interview by Frederic Flach.
    Ismail MS
    Essent Psychopharmacol; 2005; 6(4):227-37. PubMed ID: 16041919
    [No Abstract]   [Full Text] [Related]  

  • 9. Early diagnosis and management of Alzheimer's disease.
    Duncan BA; Siegal AP
    J Clin Psychiatry; 1998; 59 Suppl 9():15-21. PubMed ID: 9720482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
    Beier MT
    Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic approaches to cognitive deficits in Alzheimer's disease.
    Peskind ER
    J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's dementia: current data review.
    Uzun S; Kozumplik O; Folnegović-Smalc V
    Coll Antropol; 2011 Dec; 35(4):1333-7. PubMed ID: 22397284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Memantine in the pharmacologic treatment of moderately severe to severe Alzheimer's disease in Spain (MEMORY study)].
    Agüera-Ortiz LF;
    Rev Neurol; 2010 Nov; 51(9):525-34. PubMed ID: 20979032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel pharmacologic approaches to the treatment of senile dementia of the Alzheimer's type (SDAT).
    Reisberg B; London E; Ferris SH; Anand R; de Leon MJ
    Psychopharmacol Bull; 1983; 19(2):220-5. PubMed ID: 6346374
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacologic management of Alzheimer's disease.
    Kumar V; Durai NB; Jobe T
    Clin Geriatr Med; 1998 Feb; 14(1):129-46. PubMed ID: 9456339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caregiver acceptance of adverse effects and use of cholinesterase inhibitors in Alzheimer's disease.
    Oremus M; Wolfson C; Vandal AC; Bergman H; Xie Q
    Can J Aging; 2007; 26(3):205-12. PubMed ID: 18238727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease: clinical features and pharmacologic management.
    Franks AS; Rawls WN
    Am J Manag Care; 1998 Apr; 4(4):595-604; quiz 606-7. PubMed ID: 10179918
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of a unified clinical trial database for Alzheimer's disease.
    Neville J; Kopko S; Broadbent S; Avilés E; Stafford R; Solinsky CM; Bain LJ; Cisneroz M; Romero K; Stephenson D;
    Alzheimers Dement; 2015 Oct; 11(10):1212-21. PubMed ID: 25676387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Alzheimer's disease: treatment effects on function and care requirements.
    Kerwin D; Claus TH
    J Am Med Dir Assoc; 2011 Feb; 12(2):99-104. PubMed ID: 21266285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on Alzheimer drugs (galantamine).
    Raskind MA
    Neurologist; 2003 Sep; 9(5):235-40. PubMed ID: 12971834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.